Home›Cell Biology›Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
Cell BiologyJoVE (Open Access)Citable · DOI
Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
DOI: 10.3791/1346-v
What you'll learn
✓Deploy aortic stents in a preclinical model using minimally invasive techniques
✓Acquire and interpret longitudinal OCT images for restenosis monitoring
✓Analyze OCT data to quantify neointimal hyperplasia and stenosis progression
✓Apply this inexpensive model to study in-stent restenosis pathobiology
Protocol
This video demonstrates how to use a preclinical inexpensive and reliable model to study pathobiological and pathophysiological processes of in-stent restenosis development. Longitudinal in vivo monitoring using OCT (Optical Coherence Tomography) and analysis of OCT images are also demonstrated.
Difficulty
advanced
Total time
~2–3 weeks per animal (including stent deployment, imaging timepoints, and analysis)
Model organism
Rat (strain not specified in abstract)
Biosafety
BSL-1
Steps
1
Understand in-stent restenosis pathophysiology
Review the biological and pathophysiological mechanisms underlying in-stent restenosis development and rationale for preclinical modeling.
▶ 00:13
2
Deploy stent into aortic vessel
Perform surgical stent placement into the aorta using the described minimally invasive procedure to establish the restenosis model.
▶ 00:57
3
Acquire optical coherence tomography images
Use OCT imaging to longitudinally monitor in-stent restenosis development and obtain cross-sectional vessel and lumen data over time.
▶ 05:59
4
Analyze OCT images for stenosis metrics
Process and quantify OCT data including neointimal area, lumen diameter, and percent stenosis using image analysis software.
▶ 07:35
5
Interpret representative restenosis results
Review typical OCT findings and quantitative outcomes demonstrating neointimal growth and lumen narrowing progression.
▶ 08:22
💬 Comments coming soon
New protocols and pitfalls, in your inbox
A short email when we add notable lab videos and failure cases. No spam, unsubscribe anytime.